SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-043013
Filing Date
2020-09-09
Accepted
2020-09-09 17:22:17
Documents
14
Period of Report
2020-09-09
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K srpt-8k_20200909.htm   iXBRL 8-K 37106
2 EX-99.1 srpt-ex991_41.htm EX-99.1 17252
3 GRAPHIC gvm1z3skjy5c000001.jpg GRAPHIC 3160
  Complete submission text file 0001564590-20-043013.txt   193905

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA srpt-20200909.xsd EX-101.SCH 5820
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20200909_lab.xml EX-101.LAB 19493
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20200909_pre.xml EX-101.PRE 11663
7 EXTRACTED XBRL INSTANCE DOCUMENT srpt-8k_20200909_htm.xml XML 3558
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 201167173
SIC: 2834 Pharmaceutical Preparations